title: Can the anticoagulant effects of dabigatran be reversed?
abstract: Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran. This drug can be used for patients who need emergency surgery or invasive procedures, as well as those with life-threatening or uncontrolled bleeding.
authors: At Presbyterian College School of Pharmacy in Clinton, S.C., Aida Rebecca Bickley is an assistant professor of pharmacy practice and critical care and Caleb Wallace is a doctor of pharmacy student. The authors have disclosed no potential conflicts of interest, financial or otherwise.
authors: Aida Rebecca
authors: AR
authors: Bickley
authors: Caleb
authors: C
authors: Wallace
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D000069604:Dabigatran / Q000494:pharmacology*; D006470:Hemorrhage; D006801:Humans
chemical_list: D000925:Anticoagulants; D000069604:Dabigatran